Hopes of ending the global HIV epidemic anytime soon are fading among health workers and scientists, who say new infections could increase for the first time in decades.

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

As Obergefell v Hodges turns 10 years, LGBTQ+ rights face renewed threats amid political shifts, impacting health care equity ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

The FDA approved Lenacapavir, the first twice-a-year injection to prevent HIV, marking a historic step in public health.

To this day, the UN estimates that one person dies from AIDs every single minute - despite the fact that effective treatement ...

The US Food and Drug Administration (FDA) has approved lenacapavir as a long-acting injectable drug to prevent HIV.

While promising, a recent breakthrough in HIV research is not a “cure” or a “vaccine”, as several posts claim on social media ...